Adagio Medical Holdings, Inc. (ADGM)
Adagio Medical Holdings, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Laguna Hills, CA, US. The stock last traded at $0.20, down 7.14% on the session, giving a market capitalisation of $4.3M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of 0.0%. Its beta of -0.19 implies it has historically moved less than the broad market.
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Adagio Medical Holdings, Inc. is most often compared with the following Healthcare names: